|
Volumn 37, Issue 9, 2005, Pages 3979-3980
|
Improved cardiovascular risk profile of patients with type 1 diabetes mellitus and renal failure after simultaneous pancreas-kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CHOLESTEROL;
CREATININE;
GLUCOSE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
LOW DENSITY LIPOPROTEIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
TRIACYLGLYCEROL;
ADULT;
BODY MASS;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CONCENTRATION (PARAMETERS);
CONFERENCE PAPER;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DIASTOLIC BLOOD PRESSURE;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY FAILURE;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
MALE;
MICROALBUMINURIA;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PERIOD;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROPHYLAXIS;
STATISTICAL SIGNIFICANCE;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
ADULT;
BODY MASS INDEX;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 1;
DIABETIC ANGIOPATHIES;
DIABETIC NEPHROPATHIES;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
KIDNEY FAILURE, CHRONIC;
LIPOPROTEINS;
MALE;
PROGNOSIS;
RISK REDUCTION BEHAVIOR;
TRIGLYCERIDES;
|
EID: 29544438322
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.09.156 Document Type: Conference Paper |
Times cited : (12)
|
References (6)
|